Cerrito, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 2.270
AS - Asia 1.554
EU - Europa 1.411
SA - Sud America 299
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 49
OC - Oceania 2
Totale 5.677
Nazione #
US - Stati Uniti d'America 2.178
SG - Singapore 719
IT - Italia 363
CN - Cina 296
PL - Polonia 269
BR - Brasile 237
SE - Svezia 187
VN - Vietnam 181
DE - Germania 142
FR - Francia 130
IN - India 64
GB - Regno Unito 51
BD - Bangladesh 47
FI - Finlandia 45
JP - Giappone 45
CA - Canada 43
IE - Irlanda 39
HK - Hong Kong 38
RU - Federazione Russa 37
ID - Indonesia 32
UA - Ucraina 29
NL - Olanda 24
TR - Turchia 24
MX - Messico 23
AR - Argentina 18
AT - Austria 18
IQ - Iraq 16
BE - Belgio 15
KR - Corea 15
ES - Italia 13
EC - Ecuador 12
IR - Iran 12
ZA - Sudafrica 11
JM - Giamaica 10
VE - Venezuela 10
EG - Egitto 8
PK - Pakistan 8
SA - Arabia Saudita 8
MA - Marocco 7
PH - Filippine 7
RO - Romania 7
CI - Costa d'Avorio 6
LT - Lituania 6
CL - Cile 5
KE - Kenya 5
LB - Libano 5
PE - Perù 5
PT - Portogallo 5
UZ - Uzbekistan 5
AM - Armenia 4
CH - Svizzera 4
CO - Colombia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
GR - Grecia 4
KZ - Kazakistan 4
NP - Nepal 4
PY - Paraguay 4
IL - Israele 3
MY - Malesia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
PA - Panama 2
TN - Tunisia 2
UY - Uruguay 2
VA - Santa Sede (Città del Vaticano) 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
DM - Dominica 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MZ - Mozambico 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
Totale 5.584
Città #
Singapore 440
Warsaw 261
Ashburn 237
Chandler 223
San Jose 217
Los Angeles 82
Ho Chi Minh City 68
New York 68
Rome 65
Dallas 63
Beijing 61
The Dalles 55
Hefei 45
Lauterbourg 43
Council Bluffs 42
Hanoi 42
Tokyo 42
Ann Arbor 39
Fairfield 39
Dublin 38
Boardman 33
Hong Kong 33
Santa Clara 33
Buffalo 31
Frankfurt am Main 29
Jakarta 29
St Louis 28
Munich 27
Wilmington 27
Milan 24
San Mateo 23
São Paulo 22
Boston 21
Seattle 21
Bremen 20
Chicago 20
Helsinki 20
Houston 20
Nanjing 19
Moscow 18
Hyderabad 17
Marseille 17
Princeton 17
Paris 16
Brussels 15
Dearborn 15
Seoul 14
Amsterdam 13
Cambridge 13
Brooklyn 12
Turku 12
Atlanta 11
Cattolica 11
North Bergen 11
Phoenix 11
Woodbridge 11
Chennai 10
Denver 10
Jacksonville 10
Kent 10
Lappeenranta 10
Orem 10
San Francisco 10
Düsseldorf 9
Montreal 9
Nuremberg 9
Redwood City 9
Stockholm 9
Toronto 9
Augusta 8
Da Nang 8
Figino 8
Izmir 8
Mexico City 8
Arezzo 7
Baghdad 7
Guangzhou 7
Haiphong 7
London 7
Abidjan 6
Bexley 6
Bologna 6
Hải Dương 6
Kingston 6
Las Vegas 6
Naples 6
Nashville 6
Poplar 6
Portsmouth 6
Vienna 6
Cairo 5
Catania 5
Charlotte 5
Cimitile 5
Ferrara 5
Guayaquil 5
Istanbul 5
Kish 5
Ottawa 5
Porto Alegre 5
Totale 3.199
Nome #
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 348
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study 311
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. 311
Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement 220
Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies 176
Epidemiology of FMF Worldwide 170
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 165
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 163
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 155
Urinary incontinence: Clinical observation on 30 patients undergoing treatment with F.R.E.M.S (Frequency Rhythmic Electrical Modulation System) 153
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 153
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 150
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 145
The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma 142
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon 141
HEPATOCATT STUDY GROUP. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. 141
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 137
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 136
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 128
Diagnostic criteria for adult-onset Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome 128
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research 125
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 124
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives 119
Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever 119
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma 118
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 115
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study 114
Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever 109
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 109
Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk 108
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 108
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real life clinical practice: a nationwide multicenter retrospective observational study 100
Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy 98
Advances in pharmacotherapeutics for hepatocellular carcinoma 94
Fever of unknown origin due to Coxiella burnetii, an unexpected guest in primary sclerosing cholangitis 92
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders 90
Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overview 76
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma – Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 67
Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers 67
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges 29
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors 21
Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management 20
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease 20
PERSoN4: A multiparametric ultrasound model to improve CEUS LI-RADS for HCC 16
The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma 11
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers 8
Present and Future Perspectives in the Treatment of Liver Fibrosis 8
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab 7
Anaphylaxis after SonoVue: A Case Report and a Literature Review 7
Gut Microbiota Biomarkers in Patients with Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors 5
Totale 5.677
Categoria #
all - tutte 22.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022208 0 0 3 17 19 4 4 42 5 16 47 51
2022/2023597 73 75 55 108 31 70 29 62 62 8 16 8
2023/2024309 17 72 17 16 10 39 19 16 2 11 37 53
2024/2025907 25 13 81 41 57 30 50 58 87 117 193 155
2025/20262.458 292 88 162 268 384 114 424 132 205 157 114 118
2026/2027534 246 201 87 0 0 0 0 0 0 0 0 0
Totale 5.677